|View printer-friendly version|
|December 05, 2005 11:57 a.m.|
|Teva Announces Final Approval Of Ribavirin Tablets|
Jerusalem, Israel, December 5, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Ribavirin Tablets, 200 mg. Shipment of this product will begin immediately.